Protein expression predicts rectal cancer outcomes

April 4, 2017

(HealthDay)—Loss of E-cadherin protein expression in the pretherapeutic biopsy of rectal cancer is associated with fewer metastases and improved survival, according to a study published online March 25 in the Journal of Digestive Diseases.

Jonas Jessberger, from the Friedrich-Alexander-Universität Erlangen-Nürnberg in Germany, and colleagues evaluated 223 patients with treated with neoadjuvant radiochemotherapy followed by surgery. Protein expression of E-cadherin and growth pattern (solid-glandular versus single-cell pattern) were assessed using 88 biopsies prior to radiochemotherapy and 213 tumor resections.

The researchers observed a significant decrease of E-cadherin expression (P = 0.002) and a significant increased single-cell growth (P = 0.001) at the invasion front in tumor samples after radiochemotherapy versus primary biopsies of the tumor. Longer metastasis-free survival (P = 0.033) and tumor-specific survival (P = 0.030) were associated with low E-cadherin in the biopsy. Single-cell growth at the front was a prognostic factor for longer tumor-specific survival (P = 0.021) after radiochemotherapy. Tumor-specific survival was independently predicted using a combination of growth pattern and the Dworak regression grade (P = 0.015).

"A combination of growth pattern and tumor regression score (RegPat-Score) showed the highest discriminatory power to identify high-risk patients," the authors writes.

Explore further: Keeping skin cancer in check—how the environment influences the tumor

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Keeping skin cancer in check—how the environment influences the tumor

January 24, 2017
Malignant melanoma is the fastest-growing type of cancer and the most fatal skin disease. Sandra Iden and her team at the Cluster of Excellence on Aging Research (CECAD) at the University of Cologne investigated the influence ...

Scientists stimulate immune system, stop cancer growth

March 1, 2017
A chemical found in tumors may help stop tumor growth, according to a new study.

MicroRNAs 203 and 205 are prognostic in cutaneous SCC

December 20, 2016
(HealthDay)—MicroRNAs (miR-203 and miR-205) could be useful prognostic markers in cutaneous squamous cell carcinoma, with distinct expression and associations, according to a study published online Dec. 11 in the British ...

Uncovering the mechanisms that support the spread of ovarian cancer

October 10, 2016
A very high mortality rate is associated with ovarian cancer, in part due to difficulties in detecting and diagnosing the disease at early stages before tumors have spread, or metastasized, to other locations in the body.

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

Recommended for you

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.

Obesity may promote resistance to antiangiogenic therapy for breast cancer

March 14, 2018
Obesity—which is already known to reduce survival in several types of cancer—may explain the ineffectiveness of angiogenesis inhibitors in the treatment of breast cancer. A research team led by Massachusetts General Hospital ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.